Iradimed (IRMD) Income from Continuing Operations (2013 - 2026)

Iradimed (IRMD) has 14 years of Income from Continuing Operations data on file, last reported at 5818000.0 in Q1 2026.

• On a quarterly basis, Income from Continuing Operations rose 24.13% year-over-year to 5818000.0 in Q1 2026; TTM through Mar 2026 was 23535571.0, a 23.31% increase from a year earlier, with the FY2025 full-year figure at 22405000.0, up 20.87% from the prior year.
• Income from Continuing Operations for Q1 2026 stood at 5818000.0, down from 6366958.0 in the prior quarter.
• Over the last five years, Income from Continuing Operations for IRMD reached as high as 6366958.0 in Q4 2025 and fell as low as 2486713.0 in Q1 2022.
• Historically, Income from Continuing Operations has averaged 4436605.53 across 5 years, with a median of 4448752.0 in 2024.
• Across the five-year window, Income from Continuing Operations jumped 120.53% in 2022 and retreated 16.59% in 2023, its largest moves.
• Year by year, Income from Continuing Operations stood at 3738027.0 in 2022, then slipped by 16.59% to 3117741.0 in 2023, then soared by 42.69% to 4448752.0 in 2024, then jumped by 43.12% to 6366958.0 in 2025, then slipped by 8.62% to 5818000.0 in 2026.
• Per Business Quant data, the three most recent Income from Continuing Operations figures were 5818000.0 in Q1 2026, 6366958.0 in Q4 2025, and 5576652.0 in Q3 2025.